Veterinary Medicines

Miloxan suspensão injectável para bovinos, ovinos e caprinos.

Authorised
  • Clostridium chauvoei, toxoid
  • Clostridium sordellii, toxoid
  • Clostridium tetani, toxoid
  • Clostridium novyi, toxoid
  • Clostridium septicum, toxoid
  • Clostridium perfringens, type B, epsilon toxoid
  • Clostridium perfringens, type C, beta toxoid
Download as PDF

Product identification

Medicine name:
Miloxan suspensão injectável para bovinos, ovinos e caprinos.
Active substance:
  • Clostridium chauvoei, toxoid
  • Clostridium sordellii, toxoid
  • Clostridium tetani, toxoid
  • Clostridium novyi, toxoid
  • Clostridium septicum, toxoid
  • Clostridium perfringens, type B, epsilon toxoid
  • Clostridium perfringens, type C, beta toxoid
Target species:
  • Cattle
  • Goat
  • Sheep
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Clostridium chauvoei, toxoid
    1.00
    90% protective dose in guinea pig
    /
    2.00
    millilitre(s)
  • Clostridium sordellii, toxoid
    1.00
    90% protective dose in guinea pig
    /
    2.00
    millilitre(s)
  • Clostridium tetani, toxoid
    2.50
    international unit(s)
    /
    2.00
    millilitre(s)
  • Clostridium novyi, toxoid
    3.50
    international unit(s)
    /
    2.00
    millilitre(s)
  • Clostridium septicum, toxoid
    2.50
    international unit(s)
    /
    2.00
    millilitre(s)
  • Clostridium perfringens, type B, epsilon toxoid
    5.00
    international unit(s)
    /
    2.00
    millilitre(s)
  • Clostridium perfringens, type C, beta toxoid
    10.00
    international unit(s)
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
    • Goat
    • Sheep
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AB01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Portugal
Available in:
  • Portugal
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health Portugal Unipessoal Lda.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • DGAV
Authorisation number:
  • 424/91 DGV
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Portuguese (PDF)
Published on: 19/06/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."